PlainBillCongress, translated.Legislation. Context. Public interest.Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Congressional Research Service
Version 00 · Introduced in House · Feb 25, 2025
Safeguarding Testing and Overdose Prevention Against Fentanyl and Xylazine Act or the STOP Fentanyl and Xylazine Act
This bill exempts the possession, sale, purchase, import, export, or transport of equipment that tests for the presence of fentanyl or xylazine from criminal penalties under the Controlled Substances Act.
People & committees
Rep. Crockett, Jasmine [D-TX-30] · D–TX
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Introduced in House
Primary sources
Text links open the official source. We also preserved the text version used in the PlainBill explanation below.
No related bills are listed in this snapshot. This does not establish whether the proposal has appeared in earlier Congresses.
Source last updated: Jul 24, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze H.R.1563 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine H.R.1563 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine H.R.1563 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine H.R.1563 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.
PlainBill explanation
Based on the full Introduced in House · 2025-02-25 text. This explanation has not received human editorial review. This overview describes the proposal’s major provisions; it does not establish what its real-world effects would be.
This bill would exempt equipment intended to detect fentanyl or xylazine in a compound from Section 422 of the Controlled Substances Act. The exemption would cover those possessing, selling, buying, importing, exporting or transporting qualifying equipment. Its scope depends on the equipment’s intended use and applies to that specific statutory section.
Section 422 of the Controlled Substances Act (21 U.S.C. 863) is amended by adding at the end the following:
This section does not apply to the possession, sale, purchase, importation, exportation, or transportation of equipment for which the intended use is to indicate the presence of fentanyl or xylazine in a compound.
Section 2 would add a subsection labeled “Clarification” to Section 422. The proposed exception covers equipment intended to indicate the presence of either fentanyl or xylazine; it does not expressly extend to equipment intended only to detect other substances.
Section 422 of the Controlled Substances Act (21 U.S.C. 863) is amended by adding at the end the following: (g) Clarification This section does not apply to the possession, sale, purchase, importation, exportation, or transportation of equipment for which the intended use is to indicate the presence of fentanyl or xylazine in a compound.
The supplied action snapshot, updated July 24, 2025, records introduction in the House on February 25, 2025, and referral that day to the Judiciary and Energy and Commerce committees for provisions within their respective jurisdictions.
Source snapshot updated 2025-07-24T14:03:06Z.
2025-02-25: Introduced in House
2025-02-25: Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
A closer look
Reviewed version: Introduced in House · 2025-02-25. These findings describe provisions and who may benefit; they are not judgments of waste, corruption, or motive.
This review covers the supplied bill text. “None identified” does not rule out provisions in later versions or accompanying reports and disclosures.
Provisions outside the bill’s main subject, or policy changes attached to appropriations.
None identified in the reviewed text
No unrelated provision or policy change attached to appropriations was identified in the complete supplied introduced text. This conclusion is limited to that version and does not establish absence in other versions or accompanying materials.
Spending directed to particular recipients or places outside ordinary competitive or formula-based allocation.
None identified in the reviewed text
No congressionally directed spending for particular recipients or places was identified in the complete supplied introduced text. This conclusion is limited to that version; accompanying earmark disclosures and committee materials were not supplied.
Narrow exceptions, exemptions, or preferential treatment that warrant a closer look.
Findings to examine
The proposal contains a narrow equipment-based statutory exemption that directly serves its main policy.
Those possessing, selling, purchasing, importing, exporting or transporting equipment intended to detect fentanyl or xylazine would receive an exemption from Section 422. This preferential treatment is defined by the equipment’s intended use and constitutes the bill’s central policy.
Section 422 of the Controlled Substances Act (21 U.S.C. 863) is amended by adding at the end the following:
This section does not apply to the possession, sale, purchase, importation, exportation, or transportation of equipment for which the intended use is to indicate the presence of fentanyl or xylazine in a compound.
Full text preserved for this analysis. Legislative record snapshot: Jul 24, 2025. How PlainBill uses AI